Public Alert No. 07/2025 – Alert on Falsified OXYCONTIN 80mg identified in the WHO European Region
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public of one batch of falsified OXYCONTIN 80mg (oxycodone hydrochloride) detected in the unregulated market in Switzerland. This was reported to the World Health Organization (WHO) by the genuine manufacturer, MUNDIPHARMA, in February 2025. The falsified product imitates the genuine OXYCONTIN […]
Investigation Report of Scamming of Foreign Companies Using Fake NAFDAC Documents by Mr. Ikoro Mang Ifendua: A Case of Fraud and Obtaining Funds by Impersonation as an Official of NAFDAC
Mr. Ikoro Mang Ifendu of 26, Park Road, Aba Abia State, born on the 2nd of January, 1973, was arrested on the 7th of February 2025 at Ogborn Hills, Aba, Abia State in a case of alleged fraud and obtaining huge funds by false pretence from unsuspecting foreigners that cuts across various countries as a […]
Public Alert No. 06/2025 – Alert on the Sale of Counterfeit Noristerat Injection 200mg in Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the sale of Chlorpheniramine and Dexamethasone injection ampoules that are mislabelled and repacked as Noristerat Injection 200mg. Samples of the counterfeit product have been reported to be found in Niger State, Bauchi State, and especially the Coordinated Wholesale Centre […]
Public Alert No. 05/2025 – Alert on the Circulation of Falsified Cikatem (Artemether 180mg/Lumefantrine 1080mg) with Falsified NAFDAC Registration Number NRN A11-100025
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public about the circulation of a confirmed falsified Cikatem (Artemether 180mg/Lumefantrine 1080mg) suspension. This product was discovered in the Coordinated Wholesale Centre (CWC) in Kano following a consumer complaint received and investigated by the post marketing surveillance (PMS) officers of the […]
Blacklisting of Aveo Pharmaceuticals and Banning of Tapentadol and Carisoprodol Combination – Tafrodol or Royal 225
A company named Aveo Pharmaceuticals, based in the outskirts of Mumbai, managed by Vinod Sharma is involved in the production, sale and exportation of a range of addiction pills containing a harmful mix of Tapentadol (a powerful opioid), and Carisoprodol, a banned muscle relaxant with addictive properties that can cause overdose, or death. The mix […]
Public Alert No. 04/2025 – Public Alert on the Illegal Exportation and Sale of Opioids to West African Countries by Aveo Pharmaceuticals
The National Agency for Food and Drugs Administration and Control (NAFDAC) is informing the public of an investigational report from BBC revealing that an Indian pharmaceutical company Aveo Pharmaceuticals is manufacturing unlicensed, highly addictive opioids and exporting them illegally to some West African countries including Ghana, Nigeria, and Cote D’Ivoire, where they are constituting a […]
Public Alert No. 03/2025 – Alert on the Sale of Counterfeit/Falsified Petsow Starnicillin (Ampicillin) 500mg found in Cameroon and Central African Republic
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the sale and distribution of falsified PETSOW STARNICILLIN 500mg purportedly manufactured by Petsow Laboratories Limited. This falsified product was reportedly circulated in Cameroon and Central African Republic. The original and registered products are STARNICILLIN (500mg) with NAFDAC Reg. No. […]
Public Alert No. 02/2025 – Illegal Distribution and Sale of Substandard and Falsified (SF) Knowit Insulin Syringe 40 IU 29g X 1/2
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the illegal circulation and marketing of a substandard and falsified Knowit Insulin Syringe 40 IU 29g X 1/2 in Nigeria. The Association of Community Pharmacists of Nigeria (ACPN) raised concern regarding the ongoing use of 40 IU/ML insulin syringes […]
Public Alert No. 01/2025 – NAFDAC has Discontinued Registration of Multi-Dose Artemether /Lumefantrine Dry Powder for Oral Suspension
The National Agency for Food and Drug Administration and Control (NAFDAC) would like to inform the public that it has discontinued the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension. This decision was made due to the instability of the reconstituted formulations, which can lead to a loss of efficacy over time. This […]
The Year 2025 – NAFDAC Director General’s Strategic Plan
Reflection on the past seven years has brought into focus the many accomplishments that have been achieved in NAFDAC and so many others to be attained. This realization has sharpened my focus on how to strategically work towards continued strengthening of the regulatory system as a needed path toward safeguarding the health of the nation. […]
